The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology
Open accessAbstract
Introduction: The relationship of diabetes to specific neuropathologic causes of dementia is incompletely understood. Methods: We used logistic regression to evaluate the association between diabetes and infarcts, Braak neurofibrillary tangle stage, and neuritic plaque score in 2365 autopsied persons. In a subset of >1300 persons with available cognitive data, we examined the association between diabetes and cognition using Poisson regression. Results: Diabetes increased odds of brain infarcts (odds ratio [OR] = 1.57, P < .0001), specifically lacunes (OR = 1.71, P < .0001), but not Alzheimer's disease neuropathology. Diabetes plus infarcts was associated with lower cognitive scores at end of life than infarcts or diabetes alone, and diabetes plus high level of Alzheimer's neuropathologic changes was associated with lower mini‐mental state examination scores than the pathology alone. Discussion: This study supports the conclusions that diabetes increases the risk of cerebrovascular but not Alzheimer's disease pathology, and at least some of diabetes' relationship to cognitive impairment may be modified by neuropathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, in clinical-autopsy studies, diabetes was associated with cognitive impairment (and the clinical diagnosis of probable AD); however, the pathologic basis for this association was vascular brain injury and not Aβ plaques and neurofibrillary degeneration [50,216].”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [216]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,852
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,007
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Montine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894
Self-citationTalbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871
Self-citationProbability of stroke: a risk profile from the Framingham Study.
Wolf, P. A., D'Agostino, R. B., Belanger, A. J., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.3.312 · Cited by 1,782 · cited 2×
“Epidemiological, clinical, and neuroimaging studies have also identified increased risk of cerebrovascular disease (CVD) linked to diabetes [19-21].”
Cited by
Sorted by citations
Items 101–200 of 232
Brain insulin signaling and cerebrovascular disease in human postmortem brain
Arvanitakis, Z., Capuano, A. W., Wang, H.-Y., Schneider, J. A., Kapasi, A., Bennett, D. A., Ahima, R. S., & Arnold, S. E. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01176-9 · Cited by 20
Self-citationManagement of Comorbidities in Older Persons With Type 2 Diabetes
Morley, J. E., Abbatecola, A. M., & Woo, J. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.05.006 · Cited by 20
Loss of corneal nerves and brain volume in mild cognitive impairment and dementia
Ponirakis, G., Hamad, H. K. A., Khan, A., Petropoulos, I. N., Gad, H., Chandran, M., Elsotouhy, A., Ramadan, M., Gawhale, P. V., Elorrabi, M., et al. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12269 · Cited by 19
Cardiovascular Risk Factors and Risk of Alzheimer Disease and Mortality: A Latent Class Approach
Ruthirakuhan, M. T., Cogo‐Moreira, H., Swardfager, W., Herrmann, N., Lanctôt, K. L., & Black, S. E. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.025724 · Cited by 21
Geriatric Syndromes in Older Adults with Diabetes
Neumiller, J. J., & Munshi, M. N. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.10.004 · Cited by 22
Type 2 diabetes and later cognitive function in older American Indians: The Strong Heart Study
Cholerton, B., Omidpanah, A., Verney, S. P., Nelson, L. A., Baker, L. D., Suchy‐Dicey, A. M., Longstreth, W. T., Jr., Howard, B. V., Henderson, J. A., Montine, T. J., et al. (2019) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5108 · Cited by 20
Is diabetes associated with increased pathological burden in Alzheimer's disease?
Sadrolashrafi, K., Craft, S., Decourt, B., Adem, A., Wilson, J. R., Miller, J., & Sabbagh, M. N. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12248 · Cited by 18
Trends in Cognitive Function Before and After Diabetes Onset
Chen, Q., Zhu, S., Shang, J., Fang, Q., Xue, Q., & Hua, J. (2024) · Neurology · doi:10.1212/wnl.0000000000209165 · Cited by 18
Crane, P. K., Walker, R. L., Sonnen, J. A., Gibbons, L. E., Melrose, R. J., Hassenstab, J. J., Keene, C. D., Postupna, N. O., Montine, T. J., & Larson, E. B. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.07.021 · Cited by 18
Shang, X., Hill, E., Liu, J., Zhu, Z., Ge, Z., Wang, W., & He, M. (2022) · Diabetic Medicine · doi:10.1111/dme.14966 · Cited by 17
Şekerci, B. S., Şekerci, A., Pasin, Ö., Durmuş, E., & SALDUZ, İ. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1120127 · Cited by 19
Tolédano, A., Rodríguez‐Casado, A., Álvarez, M., & Toledano‐Díaz, A. (2024) · Brain Sciences · doi:10.3390/brainsci14111101 · Cited by 19
Peters, R. K., Breitner, J. C. S., James, S., Jicha, G. A., Meyer, P., Richards, M., Smith, A. D., Yassine, H. N., Abner, E. L., Hainsworth, A. H., et al. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12202 · Cited by 19
Self-citationSheng, J., Liu, J., & Chan, K. H. K. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.833734 · Cited by 17
Association between diabetes and causes of dementia: Evidence from a clinicopathological study
Matioli, M. N. P. D. S., Suemoto, C. K., Rodriguez, R. D., Farias, D. S., da Silva, M. M., Leite, R. E. P., Ferretti‐Rebustini, R. E. D. L., Pasqualucci, C. A., Filho, W. J., Grinberg, L. T., et al. (2017) · Dementia & Neuropsychologia · doi:10.1590/1980-57642016dn11-040010 · Cited by 17
Rantanen, K. K., Strandberg, A. Y., Salomaa, V. V., Pitkälä, K. H., Tilvis, R. S., Tienari, P. J., & Strandberg, T. E. (2017) · Annals of Medicine · doi:10.1080/07853890.2017.1290821 · Cited by 16
Biswas, R., Capuano, A. W., Mehta, R. I., Barnes, L. L., Bennett, D., & Arvanitakis, Z. (2025) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70032 · Cited by 16
Self-citationZeng, J., Hu, K., Wang, Z., Huang, Y.-C., Zhang, Y., Peng, H., & Ma, S. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00086 · Cited by 18
Grasset, L., Frison, É., Helmer, C., Catheline, G., Chêne, G., & Dufouil, C. (2024) · European Journal of Epidemiology · doi:10.1007/s10654-023-01080-7 · Cited by 15
Leino, M., Popova, S. N., & Alafuzoff, I. I. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170192 · Cited by 15
Stepler, K. E., & Robinson, R. A. S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-05542-4_1 · Cited by 15
Valentine, D., Teerlink, C. C., Farnham, J. M., Rowe, K. G., Kaddas, H. K., Tschanz, J. T., Kauwe, J. S. K., & Cannon‐Albright, L. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192416419 · Cited by 14
Prediction of neuropathologic lesions from clinical data
Phongpreecha, T., Cholerton, B., Bukhari, S. A., Chang, A. L., Francesco, D. D., Thuraiappah, M., Godrich, D., Perna, A., Becker, M., Ravindra, N. G., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12921 · Cited by 14
Neuroinflammation, Type 2 Diabetes, and Dementia
Wong, C. H. Y., Wanrooy, B. J., & Bruce, D. G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809454-9.00010-x · Cited by 14
Impact of metabolic dysfunction on cognition in humans
Rasmussen, I. J., Thomassen, J. Q., & Frikke‐Schmidt, R. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000723 · Cited by 14
Relationship between cognitive function in individuals with diabetic foot ulcer and mortality
Sela, Y., Grinberg, K., Cukierman‐Yaffe, T., & Natovich, R. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00901-1 · Cited by 14
Region-specific susceptibility change in cognitively impaired patients with diabetes mellitus
Park, M., Moon, W., Moon, Y., Choi, J. W., Han, S., & Wang, Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205797 · Cited by 14
Kakraba, S., Ayyadevara, S., Mainali, N., Balasubramaniam, M., Bowroju, S., Penthala, N. R., Atluri, R., Barger, S. W., Griffin, S. T., Crooks, P. A., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16101498 · Cited by 10
Arvanitakis, Z., Capuano, A. W., Tong, H., Mehta, R. I., Anokye‐Danso, F., Bennett, D. A., Arnold, S. E., & Ahima, R. S. (2024) · Annals of Neurology · doi:10.1002/ana.26882 · Cited by 13
Self-citationSun, H. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170059 · Cited by 13
Oveisgharan, S., Yu, L., Capuano, A. W., Arvanitakis, Z., Barnes, L. L., Schneider, J. A., Bennett, D. A., & Buchman, A. S. (2021) · Stroke · doi:10.1161/strokeaha.120.030226 · Cited by 14
Self-citationMullane, K., & Williams, M. J. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.01.004 · Cited by 13
Luo, T., Tu, Y., Huang, S., Ma, Y., Wang, Q., Wang, Y., Wang, J., & Initiative, A. D. N. (2023) · European Journal of Neurology · doi:10.1111/ene.15868 · Cited by 13
Hwangbo, S., Kim, Y. J., Park, Y. H., Kim, H. J., Na, D. L., Jang, H., & Seo, S. W. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.934149 · Cited by 10
Association of Low Systolic Blood Pressure with Postmortem Amyloid-β and Tau
Oveisgharan, S., Capuano, A. W., Kapasi, A., Buchman, A. S., Schneider, J. A., Bennett, D. A., & Arvanitakis, Z. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200412 · Cited by 11
Self-citationHigh consumption of sucrose induces DNA damage in male Wistar rats
Franke, S. I. R., Molz, P., MAI, C., Ellwanger, J. H., Zenkner, F. F., Horta, J. A., & Prá, D. (2017) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201720160659 · Cited by 11
Repurposing GLP1 agonists for neurodegenerative diseases
Markaki, I., Winther, K., Catrina, S., & Svenningsson, P. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.02.007 · Cited by 11
Tahmi, M., Benitez, R., & Luchsinger, J. A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240495 · Cited by 11
Matrix metalloproteinase 14 modulates diabetes and Alzheimer’s disease cross-talk: a meta-analysis
Cheng, J., Liu, H.-P., Lee, C.-C., Chen, M.-Y., Lin, W., & Tsai, F. (2017) · Neurological Sciences · doi:10.1007/s10072-017-3166-4 · Cited by 12
Cui, J., Robert, C., Teh, C. M., Yi, E. C. J., Chong, J. R., Tan, B. Y., Venketasubramanian, N., Lai, M. K. P., Chen, C., & Hilal, S. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01577-7 · Cited by 11
Shinohara, M., Kikuchi, M., Onishi‐Takeya, M., Tashiro, Y., Suzuki, K., Noda, Y., Takeda, S., Mukouzono, M., Nagano, S., Fukumori, A., et al. (2021) · FASEB BioAdvances · doi:10.1096/fba.2020-00151 · Cited by 9
Plasma NfL is associated with mild cognitive decline in patients with diabetes
Marutani, N., Akamine, S., Kanayama, D., Gotoh, S., Yanagida, K., Maruyama, R., Mori, K., Miyamoto, T., Adachi, H., Sakagami, Y., et al. (2022) · Psychogeriatrics · doi:10.1111/psyg.12819 · Cited by 9
Association of plasma β-amyloid 40 and 42 concentration with type 2 diabetes among Chinese adults
Peng, X., Xu, Z., Mo, X., Guo, Q., Yin, J., Xu, M., Peng, Z., Sun, T., Zhou, L., Peng, X., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05102-x · Cited by 10
Diabetes-Specific Dementia: A Structured Literature Review of Cognitive Assessment Methods
Faaitiiti, K. L., & Jupiter, D. C. (2021) · The Journal of Foot & Ankle Surgery · doi:10.1053/j.jfas.2021.11.003 · Cited by 9
Dystonin/BPAG1 modulates diabetes and Alzheimer’s disease cross-talk: a meta-analysis
Cheng, J., Liu, H., Hwang, S., Hsu, L., Lin, W., & Tsai, F. (2019) · Neurological Sciences · doi:10.1007/s10072-019-03879-3 · Cited by 10
Chen, C., Zheng, X., Liao, S., Chen, S., Liang, M., Tang, K., Yin, M., Liu, H., & Ni, J. (2024) · BMC Public Health · doi:10.1186/s12889-024-18887-y · Cited by 8
Capuano, A. W., Sarsani, V., Tasaki, S., Mehta, R. I., Li, J., Ahima, R. S., Arnold, S. E., Bennett, D. A., Petyuk, V., Liang, L., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14460 · Cited by 8
Self-citationAssociation of Cardiovascular Health and Cognition
Kulshreshtha, A., Saini, J., German, T., & Alonso, Á. (2019) · Current Epidemiology Reports · doi:10.1007/s40471-019-00210-8 · Cited by 8
Zhou, H., Hu, J., Xie, P., Dong, Y., Chen, W., Wu, H., Jiang, Y., Lei, H. C., Luo, G., & Liu, J. (2022) · PeerJ · doi:10.7717/peerj.13069 · Cited by 8
Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old
Lachner, C., Day, G. S., Camsari, G. B., Kouri, N., Ertekin‐Taner, N., Boeve, B. F., Labuzan, S. A., Lucas, J. A., Thompson, E. A., Siddiqui, H., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220440 · Cited by 8
Maciejczyk, A., & Blecharz‐Klin, K. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118743 · Cited by 8
Mesenchymal Stem Cell-Derived Exosomes: A Novel Approach to Diabetes-Associated Cognitive Impairment
Ran, Q., He, T., Lin, J. X., Wang, H., Wang, B., Chen, Z., Song, D. F., & Gong, C. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s429532 · Cited by 7
Barthold, D., Gibbons, L. E., Marcum, Z. A., Gray, S. L., Keene, C. D., Grabowski, T. J., Postupna, N. O., Larson, E. B., & Crane, P. K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210059 · Cited by 8
Factors Associated With Post-Stroke Cognitive Impairment: A Narrative Review
Shin, S., Yeo, S. M., Lee, B. C., & Chang, W. H. (2024) · Brain & Neurorehabilitation · doi:10.12786/bn.2024.17.e20 · Cited by 6
Sanchís-Soler, G., Tortosa‐Martínez, J., Manchado, C., & Cortell-Tormo, J. M. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.01.002 · Cited by 6
Manzali, S., Yu, E., Ravona‐Springer, R., Livny, A., Golan, S., Ouyang, Y., Lesman‐Segev, O. H., Liu, L., Ganmore, I., Alkelai, A., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.853695 · Cited by 5
Tran, T. H., Thi, M. L. N., Son, N. T., Bui, Q.-B., Ai-Le, P. H., & Nhac-Vu, H.-T. (2019) · Materials Research Bulletin · doi:10.1016/j.materresbull.2019.110580 · Cited by 6
Celebrating 40 years of the University of Kentucky Alzheimer's Disease Research Center
Schmitt, F. A., Abner, E. L., Fardo, D. W., Gold, B. T., Jicha, G. A., Kryscio, R. J., Lee, D. C., Nelson, P. T., & Eldik, L. J. V. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70181 · Cited by 7
Self-citationWhite Matter Hyperintensities Moderate the Association Between Diabetes and Non-AD Brain Atrophy
Cui, J., Liu, Z., Tan, W. Y., Chong, J. R., On, S. H., Chong, E. J. Y., Venketasubramanian, N., Lai, M. K. P., Chen, C., Hilal, S., et al. (2025) · Diabetes Care · doi:10.2337/dc25-1162 · Cited by 5
Santos-Ortega, Á., Alba‐Linero, C., Urbinati, F., Rocha‐de‐Lossada, C., Orti, R., Bueno, J. A. R., Garzón-Maldonado, F. J., Serrano, V., de Rojas-Leal, C., Cosme, C. D. L. C., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12227035 · Cited by 5
Vascular risk factors and cerebrovascular pathologic changes on autopsy: The 90+ Study
Rajmohan, R., Al‐Darsani, Z., Ho, C., Wong, J. Y., Paganini‐Hill, A., Montine, T. J., Corrada, M. M., & Kawas, C. H. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14454 · Cited by 5
Zhu, Y. N., Fang, Q., Zhou, Y., Lu, W., Du, X., & Shi, B. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02662-w · Cited by 5
Serum noncholesterol sterols in Alzheimer's disease: the Helsinki Businessmen Study
Sittiwet, C., Simonen, P. P., Nissinen, M. J., Gylling, H., & Strandberg, T. E. (2018) · Translational research · doi:10.1016/j.trsl.2018.07.002 · Cited by 5
Lesman‐Segev, O. H., Golan, S., Ravona‐Springer, R., Livny, A., Lin, H., Ouyang, Y., Zadok, M., Ganmore, I., Heymann, A. D., Hoffmann, C., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-53043-x · Cited by 5
The “Hit and Run” Hypothesis for Alzheimer’s Disease Pathogenesis
Ganz, T., & Ben‐Hur, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063245 · Cited by 5
Cognitive Dysfunction in Diabetes Mellitus
Biessels, G. J., & Ryan, C. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00088-2 · Cited by 6
Cerebrovascular pathology and Alzheimer's disease
Nelson, P. T. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30038-2 · Cited by 5
Self-citationEpidemiology of Type 2 Diabetes and Dementia
Gustafson, D., & McFarlane, S. I. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809454-9.00002-0 · Cited by 5
Ibrahim, O. M., & Hassan, M. A. (2018) · Pharmacology & Pharmacy · doi:10.4236/pp.2018.96013 · Cited by 4
Biomarkers for Alzheimer's disease are upregulated in patients with diabetic retinopathy
Subramanian, M. L., Sampani, K., Ness, S. D., Tuz‐Zahra, F., Alluri, S., Chen, X., Siegel, N. H., Aytan, N., Xia, W., Tripodis, Y., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251378759 · Cited by 4
Correlation Between Serum β2-GPI/oxLDL and the Risk of Cerebral Infarction in Patients with T2DM
Kuang, W., Li, Y., Liu, G., Zhang, Y., Chen, G., Luo, B., & Kuang, S.-Y. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.930701 · Cited by 4
Şekerci, B. S., Pasin, Ö., Egeli, D., Gönenç, S., & Şekerci, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-74741-6 · Cited by 4
Hugenschmidt, C. E. (2016) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-016-0093-2 · Cited by 4
Zhang, X., Schmitt, F. A., Caban‐Holt, A., Ding, X., Kryscio, R. J., & Abner, E. L. (2017) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2017.7 · Cited by 4
Self-citationŞekerci, B. S., Velioğlu, H. A., & Şekerci, A. (2024) · Brain and Behavior · doi:10.1002/brb3.3533 · Cited by 4
Sugimoto, T., Crane, P. K., Choi, S., Fujita, K., Gallée, J., Kuroda, Y., Lee, M. K., Matsumoto, N., Nakamura, A., Noma, H., et al. (2025) · Journal of Aging Research and Lifestyle · doi:10.1016/j.jarlif.2025.100016 · Cited by 3
Ismail, M., Alsalahi, A., Khaza’ai, H., Imam, M. U., Ooi, D. J., Samsudin, M. N., ZULKIFLI, I., Sokhini, M. H. M., & Aljaberi, M. A. A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17155410 · Cited by 3
Localization of Thioredoxin-Interacting Protein in Aging and Alzheimer’s Disease Brains
Tsubaki, H., Mendsaikhan, A., Buyandelger, U., Tooyama, I., & Walker, D. G. (2022) · NeuroSci · doi:10.3390/neurosci3020013 · Cited by 3
Toppala, S., Ekblad, L. L., Viitanen, M. H., Rinne, J. O., & Jula, A. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220894 · Cited by 3
Liu, T., Lo, W., Chen, J., Wang, J., & Li, C. (2024) · Geriatric Nursing · doi:10.1016/j.gerinurse.2024.10.038 · Cited by 3
Type 2 Diabetes, Glycemia, and Brain Health: The Complexity of Causality
Srikanth, V. K. (2021) · Diabetes · doi:10.2337/dbi21-0018 · Cited by 3
Li, L., Li, C., Li, Z., & Zhu, J. (2025) · Medicine · doi:10.1097/md.0000000000045602 · Cited by 2
Glans, I., Mattsson, N., Strandberg, O. T., Stomrud, E., Ossenkoppele, R., van Westen, D., Spotorno, N., Hansson, O., & Palmqvist, S. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100448 · Cited by 2
Amyloid β-Peptide Effects on Glucose Regulation Are Dependent on Apolipoprotein E Genotype
Sung, J. H., Ou, Y., & Barger, S. W. (2023) · eNeuro · doi:10.1523/eneuro.0376-22.2023 · Cited by 2
Association of late‐life variability in hemoglobin A1C with postmortem neuropathologies
Biswas, R., Capuano, A. W., Mehta, R. I., Bennett, D. A., & Arvanitakis, Z. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14471 · Cited by 2
Self-citationRodríguez‐Casado, A., Álvarez, M., Merino, J. J., Tolédano, A., & Tolédano, A. (2025) · Current Alzheimer Research · doi:10.2174/0115672050375461250325074826 · Cited by 3
Asante, J., Nagel, C., & Barger, S. W. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251351629 · Cited by 2
Clinical Update on Nursing Home Medicine: 2017
Messinger‐Rapport, B. J., Little, M. O., Morley, J. E., & Gammack, J. K. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.09.001 · Cited by 2
Blennow, K., & Zetterberg, H. (2022) · International perspectives on aging · doi:10.1007/978-3-030-78063-0_7 · Cited by 3
Brain Structural Alterations Common to Cardiovascular Disease Risk Factors and Alzheimer’s Dementia
Lamar, M., Boots, E. A., Arfanakis, K., Barnes, L. L., & Schneider, J. A. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780190634230.003.0011 · Cited by 2
Self-citationAnalysis of Link between Brain Insulin Resistance and Alzheimer's Disease: A Systematic ReviewPreprint
Andrade, L. J. D. O., de Oliveira, L. M., Bittencourt, A. M. V., Lourenço, L. G. D. C., & de Oliveira, G. C. M. (2023) · Research Square · doi:10.21203/rs.3.rs-2852332/v1 · Cited by 2
Pedersen, F. N., Stokholm, L., Pouwer, F., Rubin, K. H., Pető, T., Frydkjær-Olsen, U., Thykjær, A. S., Andersen, N., Andresen, J., Bek, T., et al. (2024) · Advances in Alzheimer's disease · doi:10.3233/aiad230037 · Cited by 1
Diabetes and cognitive impairment—insights for early diagnosis and management
Mishra, R., Kumar, V. U., Murti, K., Gupta, A. K., Kumar, N., & Quadri, K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33355-2.00026-8 · Cited by 1
Mundo, S. R. (2026) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2026.1888548 · Cited by 1
Brain Imaging in Type 2 Diabetes
Moran, C., Beare, R. J., Phan, T. G., & Srikanth, V. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809454-9.00004-4 · Cited by 1
Gut Microbiome and Cognitive Functions in Metabolic Diseases
Motger‐Albertí, A., & Fernández‐Real, J. M. (2023) · Endocrinology · doi:10.1007/978-3-031-08115-6_12-1 · Cited by 2
Diabetes affects AD through plasma Aβ40: A Mendelian randomization study
Yang, Q., Huang, D., Zhang, Z., Gao, H., Wu, J., Zhong, H., Guo, X., Wang, Y., Zhou, H., Liu, C., et al. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.04.025 · Cited by 1
Neuropathological Insights Into the Link Between Type 2 Diabetes and Dementia
Pruzin, J. J., Nelson, P. T., Abner, E. L., & Arvanitakis, Z. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809454-9.00006-8 · Cited by 1
Self-citationGandy, S., & Huffman, D. M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901970116 · Cited by 1
GANGGUAN PENGHIDU SEBAGAI FAKTOR RISIKO PENURUNAN FUNGSI KOGNITIF PADA LANSIA PENDIDIKAN RENDAH
Turana, Y. (2020) · Majalah Kedokteran Neurosains Perhimpunan Dokter Spesialis Saraf Indonesia · doi:10.52386/neurona.v37i1.95 · Cited by 1
Metadata
- Authors
- Abner, E. L., Nelson, P. T., Kryscio, R. J., Schmitt, F. A., Fardo, D. W., Woltjer, R. L., Cairns, N. J., Yu, L., Dodge, H. H., Xiong, C., Masaki, K., Tyas, S. L., Bennett, D. A., Schneider, J. A., & Arvanitakis, Z.
- Affiliations
- University of Kentucky (US)
- Oregon Health & Science University (US)
- Washington University in St. Louis (US)
- Rush University Medical Center (US)
- University of Hawaiʻi at Mānoa (US)
- University of Waterloo (CA)
- Corresponding author
- Abner, Erin L.
- ORCID
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2016-01-23
- Volume
- 12
- Issue
- 8
- Pages
- 882-889
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- PMC
- PMC4958598
- OpenAlex
- W2287966587
- Cited by
- 233
- References
- 53
- Citations by year
- 2026: 9 · 2025: 20 · 2024: 20 · 2023: 18 · 2022: 32 · 2021: 20 · 2020: 25 · 2019: 29 · 2018: 19 · 2017: 29 · 2016: 12
- FWCI
- 26.36
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Alzheimer s & Dementia (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UKnowledge (University of Kentucky) (submittedVersion, cc-by-nc-nd)
- Funders
- National Institute on Aging (R01‐AG038651, P30‐AG10161, R01‐AG15819, R01‐AG17917, P30‐AG028383, P50‐AG005681, P30‐AG008017, N01‐AG‐4‐2149, U01‐AG019349, U01‐AG017155)
- National Heart, Lung, and Blood Institute (N01‐HC‐05102)
- U.S. Department of Veterans Affairs
- National Institute of Neurological Disorders and Stroke (R01‐NS084965)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- diabetes mellitus, cerebrovascular disease
- MeSH terms
- Aged, 80 and over, Alzheimer Disease, Animals, Autopsy, Brain, Cognition Disorders, Diabetes Mellitus, Female, Humans, Male, Mental Status Schedule, Neuropsychological Tests, Cohort Studies, Logistic Models, Neurofibrillary Tangles, Brain Infarction, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review